Trials / Completed
CompletedNCT01265459
Different Volumes of Durolane in Knee OA
Double-Blind, Randomized Study of Three Different Volumes of Durolane in Subjects With Osteoarthritis of the Knee
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the safety and efficacy profiles of new single-injection volumes of Durolane in patients with knee OA.
Detailed description
To assess the safety and efficacy profiles of different volumes of Durolane in patients with knee OA and compare with the current standard single-injection of the product. The study aims to investigate whether different volumes of Durolane compared to the standard injection volume will improve the benefit/risk profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Durolane 3 ml, Durolane 4,5 ml, Durolane 6 ml | Durolane is an intraarticular hyaluronic acid preparation |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-09-01
- Completion
- 2011-11-01
- First posted
- 2010-12-23
- Last updated
- 2022-09-22
- Results posted
- 2014-01-20
Locations
3 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01265459. Inclusion in this directory is not an endorsement.